EndoQuest Robotics vs athenahealth
Side-by-side comparison of AI visibility scores, market position, and capabilities
Flexible endoluminal surgical robot for GI procedures. $232M raised (Series D-2, Jul 2025); FDA-approved PARADIGM pivotal trial underway at Mayo Clinic, Cleveland Clinic, and Brigham and Women's.
About
EndoQuest Robotics is developing the Endoluminal Surgical (ELS) System, a flexible robotic platform designed for minimally invasive gastrointestinal surgery performed entirely through natural orifices — without external incisions. The system is engineered for therapeutic endoscopists and colorectal surgeons performing complex upper and lower GI procedures, including endoscopic submucosal dissection (ESD). EndoQuest closed a Series D-2 round in July 2025, co-led by Crescent Enterprises and Dr. Fred Moll (founder of Intuitive Surgical), bringing total funding to $232M. The FDA-authorized PARADIGM pivotal trial is actively enrolling 50 patients at five leading U.S. institutions — including Mayo Clinic, Cleveland Clinic, Brigham and Women''s Hospital, AdventHealth, and HCA Healthcare — with first ESD procedures completed in 2025. The FDA has cleared the final stage of the trial.
$1.7B annual revenue; 160K+ providers, 117M patients; 18.15% EHR market share; 6,713+ companies using 2025; acquired by Bain Capital & Hellman & Friedman Nov 2021 at $17B; AI interoperability 2025
About
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on the principle that healthcare administration should be managed as a service — with athenahealth absorbing the complexity of payer rule updates, regulatory compliance, and billing workflows so that physicians and clinical staff can focus entirely on patient care. Its cloud-native architecture, deployed before most EHR competitors moved to the cloud, remains a core technical differentiator.\n\nathenahealth's platform — athenaOne — integrates EHR, revenue cycle management, patient engagement, and care coordination in a single system used by over 160,000 providers across 117 million patient records. The company serves ambulatory practices ranging from solo physicians to large health systems and medical groups. Its continuously updated rules engine processes millions of payer transactions daily, enabling higher clean claim rates and faster reimbursement compared to on-premise EHR alternatives. athenahealth holds an 18.15% share of the US ambulatory EHR market.\n\nathenahealth is currently owned by a private equity consortium of Bain Capital and Hellman & Friedman, which acquired the company in 2019 for $5.7 billion. Annual revenue stands at approximately $1.7 billion. The company competes with Epic, eClinicalWorks, and Oracle Health in the ambulatory EHR market. Its managed-service model, shared payer network data, and cloud-native infrastructure continue to make it a compelling choice for ambulatory providers who prioritize revenue cycle performance and reduced administrative burden.
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.